Prudential PLC Bristol Myers Squibb CO Transaction History

Prudential PLC

$19.6 Billion
Q3 2024

A detailed history of Prudential PLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Prudential PLC holds 304,104 shares of BMY stock, worth $17.6 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares

304,104

Previous 388,914 21.81%

Holding current value

$17.6 Million

Previous $16.2 Million 2.56%

% of portfolio

0.08%

Previous 0.11%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$39.66 - $51.75 $3.36 Million - $4.39 Million	-84,810 Reduced 21.81%	304,104 $15.7 Million
Q2 2024 Aug 06, 2024	BUY	$40.25 - $52.99 $647,864 - $852,927	16,096 Added 4.32%	388,914 $16.2 Million
Q1 2024 May 14, 2024	BUY	$47.98 - $54.4 $5.53 Million - $6.27 Million	115,189 Added 44.71%	372,818 $20.2 Million
Q4 2023 Feb 13, 2024	BUY	$48.48 - $57.85 $1.98 Million - $2.36 Million	40,810 Added 18.82%	257,629 $13.2 Million
Q3 2023 Nov 09, 2023	SELL	$57.89 - $64.73 $230,228 - $257,431	-3,977 Reduced 1.8%	216,819 $12.6 Million
Q2 2023 Aug 14, 2023	SELL	$63.71 - $70.74 $1.51 Million - $1.67 Million	-23,654 Reduced 9.68%	220,796 $14.1 Million
Q1 2023 May 12, 2023	SELL	$65.71 - $74.53 $541,450 - $614,127	-8,240 Reduced 3.26%	244,450 $16.9 Million
Q4 2022 Feb 08, 2023	BUY	$68.48 - $81.09 $3.44 Million - $4.07 Million	50,249 Added 24.82%	252,690 $18.2 Million
Q3 2022 Nov 14, 2022	BUY	$0.13 - $76.84 $7,964 - $4.71 Million	61,266 Added 43.4%	202,441 $14.4 Million
Q2 2022 Aug 12, 2022	BUY	$72.62 - $79.98 $2.74 Million - $3.02 Million	37,707 Added 36.44%	141,175 $10.9 Million
Q1 2022 May 13, 2022	BUY	$61.48 - $73.72 $3.22 Million - $3.86 Million	52,339 Added 102.37%	103,468 $7.56 Million
Q4 2021 Feb 11, 2022	BUY	$53.63 - $62.52 $2.17 Million - $2.53 Million	40,390 Added 376.11%	51,129 $3.19 Million
Q3 2021 Nov 10, 2021	BUY	$59.17 - $69.31 $635,426 - $744,320	10,739 New	10,739 $635,000
Q4 2020 Feb 08, 2021	SELL	$57.74 - $65.43 $691,090 - $783,131	-11,969 Closed	0 $0
Q3 2020 Oct 30, 2020	BUY	$57.43 - $63.64 $155,520 - $172,337	2,708 Added 29.24%	11,969 $722,000
Q2 2020 Jul 31, 2020	SELL	$54.82 - $64.09 $115,450 - $134,973	-2,106 Reduced 18.53%	9,261 $544,000
Q1 2020 May 01, 2020	SELL	$46.4 - $67.43 $1.42 Million - $2.06 Million	-30,531 Reduced 72.87%	11,367 $634,000
Q4 2019 Feb 13, 2020	SELL	$49.21 - $64.19 $193 Million - $251 Million	-3,914,386 Reduced 98.94%	41,898 $2.69 Million
Q3 2019 Nov 13, 2019	BUY	$42.77 - $50.71 $44.9 Million - $53.2 Million	1,048,783 Added 36.07%	3,956,284 $202 Million
Q2 2019 Aug 14, 2019	BUY	$44.62 - $49.34 $106 Million - $117 Million	2,367,644 Added 438.57%	2,907,501 $131 Million
Q1 2019 May 13, 2019	BUY	$45.12 - $53.8 $5.34 Million - $6.37 Million	118,406 Added 28.09%	539,857 $25.8 Million
Q4 2018 Feb 13, 2019	BUY	$48.76 - $63.23 $19.7 Million - $25.5 Million	404,043 Added 2321.02%	421,451 $21.9 Million
Q3 2018 Nov 14, 2018	SELL	$55.19 - $62.25 $46,525 - $52,476	-843 Reduced 4.62%	17,408 $1.08 Million
Q2 2018 Aug 14, 2018	BUY	$50.53 - $62.98 $131,378 - $163,748	2,600 Added 16.61%	18,251 $1.01 Million
Q1 2018 May 15, 2018	SELL	$59.92 - $68.98 $165,858 - $190,936	-2,768 Reduced 15.03%	15,651 $990,000
Q4 2017 Feb 14, 2018	BUY	$59.94 - $65.35 $37,042 - $40,386	618 Added 3.47%	18,419 $1.13 Million
Q3 2017 Nov 14, 2017	BUY	$55.23 - $63.74 $66,276 - $76,488	1,200 Added 7.23%	17,801 $1.13 Million
Q2 2017 Aug 14, 2017	BUY	N/A	16,601	16,601 $925,000

Others Institutions Holding BMY

# of Institutions

2,536

Shares Held

1.47B

Call Options Held

31.6M

Put Options Held

35M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $123B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Prudential PLC, based on Form 13F filings with the SEC.

News

Stay updated on Prudential PLC with notifications on news.

Account